Ignite Creation Date:
2024-05-05 @ 10:40 PM
Last Modification Date:
2024-10-26 @ 10:22 AM
Study NCT ID:
NCT01160445
Status:
TERMINATED
Last Update Posted:
2015-10-28
First Post:
2010-07-09
Brief Title:
Phase II Study of Aldesleukin IL-2 Following the Administration of Zanolimumab Anti-CD4mAb in Metastatic Melanoma and Metastatic Renal Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Organization Data
Organization:
National Institutes of Health Clinical Center CC
Class:
NIH
Study ID:
100145
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cancer Institute NCI
Lead Sponsor Class:
NIH
Responsible Party:
Steven Rosenberg MD
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
National Institutes of Health Clinical Center CC
Old Name:
None
Old Organization:
None